Concepedia

Author

Abena B. Redwood

The University of Texas MD Anderson Cancer Center

Also Known As

A Redwood, Abena B Redwood, Abena B. Redwood, Abena Redwood, Redwood, Abena

54

Publications

1.4K

Citations

13

H-Index

25

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterWashington University in St. LouisInstitute of Medical BiologySaint Louis UniversityStanford University
AB

About

Abena B. Redwood is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and molecular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

326

2

Cell Biology

3

3

326

3

Natural Sciences

2

2

245

4

Molecular Biology

2

2

245

5

Health Sciences

1

1

81

Abena B. Redwood

×

12

Publications

1.2K

Citations

11

H-Index

YearCitations

Loss of lamin A function increases chromatin dynamics in the nuclear interior

I. N. Bronshtein, Eldad Kepten, Itamar Kanter,

Nature Communications

2015

298

Novel roles for A‐type lamins in telomere biology and the DNA damage response pathway

Ignacio González-Suárez, Abena B. Redwood, Stephanie M. Perkins,

The EMBO Journal

2009

247

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen, Pan Tong, C. Allison Stewart,

Cancer Research

2017

189

A dual role for A-type lamins in DNA double-strand break repair

Abena B. Redwood, Stephanie M. Perkins, Robert P. Vanderwaal,

Cell Cycle

2011

138

A new pathway that regulates 53BP1 stability implicates Cathepsin L and vitamin D in DNA repair

Ignacio González-Suárez, Abena B. Redwood, David A Grotsky,

The EMBO Journal

2011

107

BRCA1 loss activates cathepsin L–mediated degradation of 53BP1 in breast cancer cells

David A Grotsky, Ignacio González-Suárez, Anna Novell,

The Journal of Cell Biology

2013

81

<i>CDKN2A/p16</i> Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition

Mayur A. Gadhikar, Jiexin Zhang, Li Shen,

Cancer Research

2017

49

6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers

Hailing Yang, Shu Zhang, Yongying Jiang,

Clinical Cancer Research

2019

46

Lamin A Δexon9 mutation leads to telomere and chromatin defects but not genomic instability

Arindam Das, David A Grotsky, Martin A Neumann,

Nucleus

2013

26

Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer

Reid T. Powell, Abena B. Redwood, Xuan Liu,

Scientific Reports

2020

21

Page 1